Oct 28HHS draft policy lets licensed pharmacies compound six peptides, including BPC-157. What changed and what did not.
Skip to content
PeptideAgent

Clinics in Colorado

By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed.  Last verified

What Colorado law means for peptide clinics: who may prescribe, whether pharmacies may compound GLP-1 drugs (limited), how to check a clinic, and listings with their verification status.

Colorado at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async allowed
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Clinics serving Colorado

No verified clinics serving Colorado are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Peptide access rules in Colorado

Yes. A Colorado resident can obtain FDA approved peptides such as semaglutide and tirzepatide by prescription, including by telehealth, from a provider who holds a Colorado license or a Colorado out-of-state telehealth registration (C.R.S. 12-30-124). Colorado law lists the delivery of telemedicine as the practice of medicine (C.R.S. 12-240-107), and the Colorado Medical Board's telehealth policies, which are guidance rather than rules, say a provider-patient relationship may be formed through telehealth but that a prescription based solely on an online questionnaire is not acceptable care. Compounded peptides are available when eligible under federal 503A rules and dispensed by a Colorado prescription drug outlet or a nonresident prescription drug outlet registered with the Colorado State Board of Pharmacy under C.R.S. 12-280-133, which must supply a recent inspection report from its home-state board or a national pharmacy verification program and may ship compounded drugs into Colorado only on patient-specific prescriptions. [1] [2] [3] [4] [5] [6] [7] [9] [11] [12] [16]

Compounded GLP-1 access in Colorado

Colorado patients using a telehealth GLP-1 program should confirm the prescriber holds a Colorado license or an out-of-state telehealth registration and that an out-of-state dispensing pharmacy appears as a registered nonresident prescription drug outlet. The Board of Pharmacy rules (3 CCR 719-1) contain no GLP-1-specific provision, and a 2026 bill to regulate the marketing and distribution of compounded GLP-1 weight-loss medication (SB26-066) was postponed indefinitely in a House committee on May 5, 2026 and did not become law, so federal compounding limits and the general Colorado rules apply. [6] [7] [9] [10] [13] [14]

Research use only sellers in Colorado

Only registered prescription drug outlets, including registered nonresident outlets, may dispense prescription drugs to Colorado patients. "Research use only" peptides sold for human injection are unapproved new drugs under federal law regardless of labeling and are not dispensed by a pharmacist. Colorado law also bars the sale directly: C.R.S. 12-280-131 says no person shall sell, deliver, offer for sale, hold for sale, or give away any new drug not authorized to move in interstate commerce under federal law, with an exception only for drugs intended solely for investigational use by qualified experts and plainly labeled for investigational use only. [7] [8] [15]

Colorado notes on specific peptides

  • Semaglutide: Available branded by prescription, including by telehealth from a provider with a Colorado license or, since January 1, 2026, an out-of-state telehealth registration under C.R.S. 12-30-124. The Medical Board's telehealth policies say a prescription based solely on an online questionnaire is not acceptable care. Compounded semaglutide is limited to documented patient-specific needs since the 503A grace period ended April 22, 2025. [3] [6] [13]

How to check a clinic in Colorado

  1. Confirm the prescribing clinician's license with the Colorado medical or nursing board.
  2. Ask which pharmacy compounds or dispenses the peptide and check it in the Colorado State Board of Pharmacy (Division of Professions and Occupations) license lookup. [1] [7] [9] [11] [12]
  3. Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Colorado. [7] [8] [15]

Common questions in Colorado

Can a telehealth provider prescribe me a GLP-1 in Colorado without an in-person visit?

Yes, if the provider holds a Colorado license or a Colorado out-of-state telehealth registration and establishes a provider-patient relationship that meets generally accepted standards of practice. Colorado law lists the delivery of telemedicine as the practice of medicine, and Colorado law defines telemedicine to include store-and-forward transfers (C.R.S. 12-240-104(6)), and the Colorado Medical Board's telehealth policies, which are guidance, say the relationship may be formed through telehealth with appropriate informed consent. The policies do not require a real-time visit, but they say a prescription based solely on an online questionnaire is not acceptable care. [3] [4] [5] [6]

All peptide legal questions for Colorado

Sources

  1. [1]Colorado State Board of Pharmacy, Division of Professions and Occupations
  2. [2]Colorado Medical Board, Division of Professions and Occupations
  3. [3]Colorado Medical Board Policies, compilation dated May 2026 (Policy 40-03 provider-patient relationship; Policy 40-27 telehealth guidelines, revised August 19, 2021), linked from the Board homepage, accessed 2026-09-30
  4. [4]C.R.S. 12-240-107, Practice of medicine defined (includes telemedicine)
  5. [5]C.R.S. 12-240-104, Definitions (subsection (6), telemedicine includes store-and-forward transfers), accessed 2026-09-30
  6. [6]C.R.S. 12-30-124, telehealth by providers with an out-of-state credential who register with a Colorado regulator (added by SB 24-141; Justia 2025 edition), accessed 2026-09-30
  7. [7]C.R.S. 12-280-133, Nonresident prescription drug outlet, registration, accessed 2026-09-22
  8. [8]C.R.S. 12-280-131, New drugs, when sales permissible, accessed 2026-09-22
  9. [9]Colorado Secretary of State, Code of Colorado Regulations 3 CCR 719-1, State Board of Pharmacy Rules (current version effective August 21, 2026; Rules 5.00.15, 21.00.00, 21.20.00), accessed 2026-09-22
  10. [10]Colorado General Assembly: SB26-066, Regulation of Compounded Weight-Loss Medication (postponed indefinitely May 5, 2026), accessed 2026-09-22